Dysregulated DNA methylation in the pathogenesis of Fabry disease
Fabry disease is an X-linked lysosomal storage disorder caused by a deficiency of α-galactosidase A and subsequent accumulation of glycosphingolipids with terminal α-D-galactosyl residues. The molecular process through which this abnormal metabolism of glycosphingolipids causes multisystem dysfuncti...
Main Authors: | Jin-Song Shen, Uthra Balaji, Kunitoshi Shigeyasu, Yoshinaga Okugawa, Siamak Jabbarzadeh-Tabrizi, Taniqua S. Day, Erland Arning, John Marshall, Seng H. Cheng, Jinghua Gu, Raphael Schiffmann, Teodoro Bottiglieri, Ajay Goel |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Molecular Genetics and Metabolism Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214426922000799 |
Similar Items
-
Clinical heterogeneity in Fabry disease: A clinical case
by: Assel Issabekova, et al.
Published: (2023-08-01) -
Correlación de la inactivación del cromosoma X con la presentación clínica de la enfermedad de Fabry a propósito de un caso
by: Pablo Rodríguez Doyágüez, et al.
Published: (2023-12-01) -
Characterization of small fiber pathology in a mouse model of Fabry disease
by: Lukas Hofmann, et al.
Published: (2018-10-01) -
Fabry Disease: Switch from Enzyme Replacement Therapy to Oral Chaperone Migalastat: What Do We Know Today?
by: Fernando Perretta, et al.
Published: (2023-02-01) -
Dysregulation of Immune Response Mediators and Pain-Related Ion Channels Is Associated with Pain-like Behavior in the GLA KO Mouse Model of Fabry Disease
by: Marlene Spitzel, et al.
Published: (2022-05-01)